SCHEMBL24735360

SCHEMBL24735360

COCC1CC(F)(F)C(n2ccc(N)nc2=O)O1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3A Q14432 3/20 0.50
▸ PDE4D Q08499 1/20 0.50
▸ SLC29A1 Q99808 1/20 0.50
▸ POLA1 P09884 2/20 0.46
▸ LMNA P02545 3/20 0.41
▸ CACNA1F O60840 2/20 0.41
▸ ALB P02768 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ CACNA1D Q01668 2/20 0.41
▸ CACNA1S Q13698 2/20 0.41
▸ CACNA1C Q13936 2/20 0.41
▸ THRB P10828 1/20 0.40
▸ MTOR P42345 1/20 0.40
▸ MDM2 Q00987 1/20 0.40
▸ NCOA1 Q15788 1/20 0.40
▸ NCOA3 Q9Y6Q9 1/20 0.40
▸ POLG P54098 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19236725 0.90 PDE3A (0.49) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL22739111 0.90 PDE3A (0.49) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL26247475 0.89 PDE3A (0.50) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL18270531 0.85 PDE3A (0.49) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL13713969 0.85 PDE3A (0.62) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL2912374 0.85 PDE3A (0.62) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL19932385 0.85 PDE3A (0.62) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL12826168 0.85 PDE3A (0.41) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL20403331 0.83 PDE3A (0.49) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL18389736 0.83 POLA1 (0.46) PDE3APDE4DSLC29A1POLA1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3351551-B1 PREPARATION METHOD OF NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS AND INTERMEDIATES THEREOF BRIGHTGENE BIO MEDICAL TECH CO LTD (CN) 2022-12-07 — — EP disclosed
Send feedback